The patient characteristics including age, sex, smoking history, serum carcinoembryonic antigen (CEA) levels, NSE levels, Cyfra21-1 levels, tumor differentiation cN2 stage, tumor size, lymph node metastasis, and staging are shown in Table 1. This evidence concerns the gene ENO2 and metastatic malignant neoplasm in the lymph nodes.